# Femasys Inc: Form 8-K, filed Nov 15, 2023

- Company: [Femasys Inc](/companies/femy.md) (CIK 1339005)
- Form: 8-K
- Filed: 2023-11-15
- Accepted by EDGAR: Nov 15, 2023, 17:19 ET
- Period: 2023-11-08
- Accession: 0001140361-23-053486
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1339005/000114036123053486/ef20014760_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1339005/000114036123053486/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.01: Delisting notice
- Item 3.02: Unregistered sale of equity
- Item 5.02: Departure or appointment of officers or directors
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1339005/000114036123053486/ef20014760_8k.htm

Filed Nov 15, 2023.
Source: SEC EDGAR, the filing index for accession 0001140361-23-053486. Last ingested by Listed: Nov 14, 2026, 22:40 ET. No prices; not investment advice.
